|
1
|
Foulkes WD, Priest JR and Duchaine TF:
DICER1: Mutations, microRNAs and mechanisms. Nat Rev Cancer.
14:662–672. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chiosea S, Jelezcova E, Chandran U,
Acquafondata M, McHale T, Sobol RW and Dhir R: Up-regulation of
Dicer, a component of the microRNA machinery, in prostate
adenocarcinoma. Am J Pathol. 169:1812–1820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Faber C, Horst D, Hlubek F and Kirchner T:
Overexpression of Dicer predicts poor survival in colorectal
cancer. Eur J Cancer. 47:1414–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bian XJ, Zhang GM, Gu CY, Cai Y, Wang CF,
Shen YJ, Zhu Y, Zhang HL, Dai B and Ye DW: Down-regulation of Dicer
and Ago2 is associated with cell proliferation and apoptosis in
prostate cancer. Tumour Biol. 35:11571–11578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai
Q, Ni D, Chen W, Zhang P, Song E, et al: Dicer is down-regulated in
clear cell renal cell carcinoma and in vitro Dicer knockdown
enhances malignant phenotype transformation. Urol Oncol.
32:46.e9–e17. 2014. View Article : Google Scholar
|
|
6
|
Karube Y, Tanaka H, Osada H, Tomida S,
Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S,
Mitsudomi T, et al: Reduced expression of Dicer associated with
poor prognosis in lung cancer patients. Cancer Sci. 96:111–115.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo X, Liao Q, Chen P, Li X, Xiong W, Ma
J, Li X, Luo Z, Tang H, Deng M, et al: The microRNA-processing
enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal
carcinoma. J Cancer Res Clin Oncol. 138:49–56. 2012. View Article : Google Scholar
|
|
8
|
Merritt WM, Lin YG, Han LY, Kamat AA,
Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick
AM, et al: Dicer, Drosha, and outcomes in patients with ovarian
cancer. N Engl J Med. 359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuang Y, Cai J, Li D, Han Q, Cao J and
Wang Z: Repression of Dicer is associated with invasive phenotype
and chemoresistance in ovarian cancer. Oncol Lett. 5:1149–1154.
2013.PubMed/NCBI
|
|
10
|
Catto JW, Miah S, Owen HC, Bryant H, Myers
K, Dudziec E, Larré S, Milo M, Rehman I, Rosario DJ, et al:
Distinct microRNA alterations characterize high- and low-grade
bladder cancer. Cancer Res. 69:8472–8481. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu D, Tao J, Xu B, Li P, Lu Q and Zhang W:
Downregulation of Dicer, a component of the microRNA machinery, in
bladder cancer. Mol Med Rep. 5:695–699. 2012.
|
|
12
|
Han Y, Liu Y, Gui Y and Cai Z: Inducing
cell proliferation inhibition and apoptosis via silencing Dicer,
Drosha, and Exportin 5 in urothelial carcinoma of the bladder. J
Surg Oncol. 107:201–205. 2013. View Article : Google Scholar
|
|
13
|
Tao J, Wu D, Li P, Xu B, Lu Q and Zhang W:
microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets
Dicer and suppresses cell proliferation in bladder cancer T24
cells. Mol Med Rep. 5:167–172. 2012.
|
|
14
|
Zeng S, Yang J, Zhao J, Liu Q, Rong M, Guo
Z and Gao W: Silencing Dicer expression enhances cellular
proliferative and invasive capacities in human tongue squamous cell
carcinoma. Oncol Rep. 31:867–873. 2014.
|
|
15
|
Moyret-Lalle C, Ruiz E and Puisieux A:
Epithelial-mesenchymal transition transcription factors and miRNAs:
'Plastic surgeons' of breast cancer. World J Clin Oncol. 5:311–322.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grelier G, Voirin N, Ay AS, Cox DG,
Chabaud S, Treilleux I, Léon-Goddard S, Rimokh R, Mikaelian I,
Venoux C, et al: Prognostic value of Dicer expression in human
breast cancers and association with the mesenchymal phenotype. Br J
Cancer. 101:673–683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nieman MT, Prudoff RS, Johnson KR and
Wheelock MJ: N-cadherin promotes motility in human breast cancer
cells regardless of their E-cadherin expression. J Cell Biol.
147:631–644. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kariko K, Malkowicz S, Li W, Kuo A and
Barnathan E: Invasive neoplastic uroepithelial cells express
high-levels of urokinase receptor and plasminogen receptor,
alpha-enolase. Int J Oncol. 3:1089–1095. 1993.PubMed/NCBI
|
|
19
|
Wu X, Obata T, Khan Q, Highshaw RA, De
Vere White R and Sweeney C: The phosphatidylinositol-3 kinase
pathway regulates bladder cancer cell invasion. BJU Int.
93:143–150. 2004. View Article : Google Scholar
|
|
20
|
Su X, Chakravarti D, Cho MS, Liu L, Gi YJ,
Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, et al:
TAp63 suppresses metastasis through coordinate regulation of Dicer
and miRNAs. Nature. 467:986–990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vasala K, Pääkkö P and
Turpeenniemi-Hujanen T: Matrix metal-loproteinase-2 immunoreactive
protein as a prognostic marker in bladder cancer. Urology.
62:952–957. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Papathoma AS, Petraki C, Grigorakis A,
Papakonstantinou H, Karavana V, Stefanakis S, Sotsiou F and Pintzas
A: Prognostic significance of matrix metalloproteinases 2 and 9 in
bladder cancer. Anticancer Res. 20:2009–2013. 2000.PubMed/NCBI
|
|
23
|
Wszolek MF, Rieger-Christ KM, Kenney PA,
Gould JJ, Silva Neto B, Lavoie AK, Logvinenko T, Libertino JA and
Summerhayes IC: A MicroRNA expression profile defining the invasive
bladder tumor phenotype. Urol Oncol. 29:794–801. e12011. View Article : Google Scholar
|
|
24
|
Wang S, Li Q, Wang K, Dai Y, Yang J, Xue
S, Han F, Zhang Q, Liu J and Wu W: Decreased expression of
microRNA-31 associates with aggressive tumor progression and poor
prognosis in patients with bladder cancer. Clin Transl Oncol.
15:849–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neely LA, Rieger-Christ KM, Neto BS,
Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Libertino
JA, Whitney D, et al: A microRNA expression ratio defining the
invasive phenotype in bladder tumors. Urol Oncol. 28:39–48. 2010.
View Article : Google Scholar
|
|
26
|
Mongroo PS and Rustgi AK: The role of the
miR-200 family in epithelial-mesenchymal transition. Cancer Biol
Ther. 10:219–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang SL and Liu L: microRNA-148a inhibits
hepatocellular carcinoma cell invasion by targeting
sphingosine-1-phosphate receptor 1. Exp Ther Med. 9:579–584.
2015.PubMed/NCBI
|
|
28
|
Pan SJ, Zhan SK, Pei BG, Sun QF, Bian LG
and Sun BM: MicroRNA-149 inhibits proliferation and invasion of
glioma cells via blockade of AKT1 signaling. Int J Immunopathol
Pharmacol. 25:871–881. 2012.
|
|
29
|
Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X,
Ding Q, Zha X, Sha J and Wang S: Downregulation of miR-106b induced
breast cancer cell invasion and motility in association with
overexpression of matrix metalloproteinase 2. Cancer Sci.
105:18–25. 2014. View Article : Google Scholar
|
|
30
|
Khoshnaw SM, Rakha EA, Abdel-Fatah TM,
Nolan CC, Hodi Z, Macmillan DR, Ellis IO and Green AR: Loss of
Dicer expression is associated with breast cancer progression and
recurrence. Breast Cancer Res Treat. 135:403–413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Faggad A, Kasajima A, Weichert W,
Stenzinger A, Elwali NE, Dietel M and Denkert C: Down-regulation of
the microRNA processing enzyme Dicer is a prognostic factor in
human colorectal cancer. Histopathology. 61:552–561.
2012.PubMed/NCBI
|
|
32
|
Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang
J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes
malignant progression by impairing microRNA biogenesis in
nasopharyngeal carcinoma. Carcinogenesis. 34:415–425. 2013.
View Article : Google Scholar
|
|
33
|
Iliou MS, da Silva-Diz V, Carmona FJ,
Ramalho-Carvalho J, Heyn H, Villanueva A, Muñoz P and Esteller M:
Impaired DICER1 function promotes stemness and metastasis in colon
cancer. Oncogene. 33:4003–4015. 2014. View Article : Google Scholar :
|
|
34
|
Tzamali E, Grekas G, Marias K and Sakkalis
V: Exploring the competition between proliferative and invasive
cancer phenotypes in a continuous spatial model. PLoS One.
9:e1031912014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang B, Chen H, Zhang L, Dakhova O, Zhang
Y, Lewis MT, Creighton CJ, Ittmann MM and Xin L: A dosage-dependent
pleiotropic role of Dicer in prostate cancer growth and metastasis.
Oncogene. 33:3099–3108. 2014. View Article : Google Scholar :
|
